Holen Sie sich die Stockscreener-App
1.48
4.52%
-0.07
Handel nachbörslich:
1.46
-0.02
-1.35%
Schlusskurs vom Vortag:
$1.55
Offen:
$1.55
24-Stunden-Volumen:
126.37K
Relative Volume:
0.14
Marktkapitalisierung:
$38.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+6.47%
1M Leistung:
+18.40%
6M Leistung:
-21.28%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.425
$1.55
1-Wochen-Bereich:
$1.36
$1.56
52-Wochen-Spanne:
$1.04
$3.50
Rein Therapeutics Inc Stock (RNTX) Company Profile
Firmenname
Rein Therapeutics Inc
Sektor
Branche
Telefon
(737) 802-1989
Adresse
12407 N. MOPAC EXPY., AUSTIN
Vergleichen Sie RNTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RNTX
Rein Therapeutics Inc
|
1.48 | 40.74M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Rein Therapeutics Inc Stock (RNTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-22 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2017-07-24 | Eingeleitet | BofA/Merrill | Buy |
| 2017-07-24 | Eingeleitet | Jefferies | Buy |
| 2017-07-24 | Eingeleitet | William Blair | Outperform |
Rein Therapeutics Inc Aktie (RNTX) Neueste Nachrichten
White House AI Czar Defends Trump Push to Rein In State Rules - Yahoo Finance
Rein Therapeutics ends agreements with Yorkville, incurs no penalties By Investing.com - Investing.com Nigeria
Rein Therapeutics ends agreements with Yorkville, incurs no penalties - Investing.com India
Rein Therapeutics Ends Key Financial Agreements - TipRanks
Rein Therapeutics ends key financial agreements - MSN
Rein Therapeutics Inc. (RNTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Rein Therapeutics Inc. stock attractive for long term wealth building2025 Winners & Losers & Comprehensive Market Scan Insights - Newser
Is Rein Therapeutics Inc. stock positioned well for digital economyAnalyst Upgrade & Low Drawdown Investment Strategies - Newser
Hedge Fund Bets: Can Rein Therapeutics Inc stock attract ESG capital inflowsJuly 2025 Price Swings & Daily Price Action Insights - BỘ NỘI VỤ
Bank Julius Baer & Co. Ltd Zurich Decreases Stock Position in Expedia Group, Inc. $EXPE - Defense World
Bank Julius Baer & Co. Ltd Zurich Sells 8,729 Shares of General Motors Company $GM - Defense World
Will Rein Therapeutics Inc. stock gain from strong economy - newser.com
Will Rein Therapeutics Inc. stock outperform Nasdaq indexMarket Movement Recap & Expert Curated Trade Setup Alerts - newser.com
Will Rein Therapeutics Inc. stock continue upward momentumJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
What drives Rein Therapeutics Inc stock priceVWAP Trading Strategies & Exceptional Growth Portfolio - earlytimes.in
Why retail investors favor Rein Therapeutics Inc. stockPortfolio Profit Report & Safe Capital Growth Tips - newser.com
Omdia: Middle East Smartphone Market up 23% in 3Q25; Supply Issues to Rein in 2026 Growth to 1% - Yahoo Finance
Voss capital reports $127k Rein Therapeutics (NASDAQ:RNTX) purchase By Investing.com - Investing.com South Africa
Voss capital reports $127k Rein Therapeutics (NASDAQ:RNTX) purchase - Investing.com India
How Rein Therapeutics Inc. stock reacts to bond yieldsWeekly Risk Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Will Rein Therapeutics Inc. stock maintain momentum in 2025Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Owner Voss Capital LP Buys 104,183 ($127.6K) Of Rein Therapeutics Inc [RNTX] - TradingView
Ranking Rein Therapeutics Inc. among high performing stocks via tools - newser.com
Comparing Rein Therapeutics Inc. in custom built stock radars2025 Bull vs Bear & Daily Oversold Bounce Ideas - newser.com
Price momentum metrics for Rein Therapeutics Inc. explained2025 Investor Takeaways & Expert Approved Trade Ideas - newser.com
Finanzdaten der Rein Therapeutics Inc-Aktie (RNTX)
Es liegen keine Finanzdaten für Rein Therapeutics Inc (RNTX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
Rein Therapeutics Inc-Aktie (RNTX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Voss Capital, LP | 10% Owner |
Oct 28 '25 |
Buy |
1.39 |
178,392 |
247,965 |
500,000 |
| Voss Capital, LP | 10% Owner |
Oct 27 '25 |
Buy |
1.37 |
97,482 |
133,544 |
822,258 |
| Voss Capital, LP | 10% Owner |
Oct 24 '25 |
Buy |
1.39 |
30,176 |
41,957 |
729,616 |
0.36%
1.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):